Ethan James Gantana

Dr. Ethan James Gantana

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 January 2021 in Southern African Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
IAIbtisam Abdullah
Ibtisam Abdullah
NSNadhiya Subramony
Nadhiya Subramony
EMErnest Musekwa
Ernest Musekwa
ENErica-Mari Nell
Erica-Mari Nell
FAFatima Alzanad
Fatima Alzanad
ZCZivanai Cuthbert Chapanduka
Zivanai Cuthbert Chapanduka
Background: Bone marrow examination is a useful diagnostic tool in human immunodeficiency virus (HIV)-positive patients presenting with cytopenias and fever. However, its role in the afebrile and asymptomatic patient presenting with an isolated cytopenia is not well established. This study was conducted to determine the indications for bone marrow examination and its diagnostic yield, in HIV-positive patients at Tygerberg Hospital. Methods: A retrospective, cross-sectional descriptive study was performed over a 3-year period from 01 September 2015 to 31 August 2018. The bone marrow examination reports for the HIV-positive patients who had a bone marrow examination during the study period were retrieved. Clinical and laboratory information was captured. Results: Altogether 374 bone marrow reports for HIV-positive patients were found. The indication of the bone marrow examination included investigation of unexplained cytopenias, suspected haematological malignancies, follow-up examination for patients with known haematological diseases, staging of haematological or non-haematological malignancies and investigation of suspected disseminated infection. The patients’ median age was 43 years and the interquartile range was 27–60 years. There was a slight female predominance with females 51% and males 49%. The diagnostic yield was 33.7%. Acute leukaemia and lymphoma were the most common diagnoses. Haematinic deficiency and pure red cell aplasia were found in the majority of cases with isolated anaemia. All cases with isolated thrombocytopenia were due to immune thrombocytopenia. Conclusion: Bone marrow examination is a useful investigation for HIV-positive patients with cytopenias, suspected haematological malignancy and lymphoma staging. However, its early use in patients with isolated anaemia and isolated thrombocytopenia is questionable.

24 August 2023 in International Journal of Laboratory Hematology
Verified
Journal Article
Open access
EGEthan James Gantana
Ethan James Gantana
ENErica‐Mari Nell
Erica‐Mari Nell
EMErnest Musekwa
Ernest Musekwa
RLRobert Kingsley Lohlun
Robert Kingsley Lohlun
CCCarissa Chetty
Carissa Chetty
ZCZivanai Cuthbert Chapanduka
Zivanai Cuthbert Chapanduka
Introduction: The diagnosis of plasma cell neoplasms depends on the accurate quantification of plasma cells, traditionally done by immunohistochemical CD138 staining of bone marrow biopsies. Currently, there is no fully satisfactory reference method for this quantification. In our previous study, we compared the commonly used overview estimation method (method A) with a novel method for counting plasma cells in three representative areas (method B). Results showed comparable concordance parameters between the two methods. In this follow‐up study, we compared the previously evaluated methods with a digital analysis method (method C) that uses artificial intelligence in open‐source software, QuPath.Methods: Archived CD138 immunohistochemically stained trephine sections of bone marrow samples used in our previous study were used (n = 33). Reviewers selected three representative areas on each sample by taking images with a light microscope and camera. Digital analysis was performed using the positive cell detection function in QuPath. The entire process was repeated by each reviewer to test intraobserver concordance (concordance correlation coefficient [CCC]) in addition to interobserver concordance (intraclass correlation coefficient [ICC]).Results: Intraobserver concordance of method C showed strong agreement for all reviewers with the lowest CCC = 0.854. Interobserver concordance for method C using ICC was 0.909 and 0.949. This showed high interobserver agreement with significant differences between method C and previously assessed method A (ICC = 0.793 and 0.713) and method B (ICC = 0.657 and 0.658).Conclusion: We were able to successfully count CD138‐positive plasma cells in bone marrow biopsies using artificial intelligence. This method is superior to both manual counting and overview estimation, regardless of tumour load.

22 December 2023 in African Journal of Laboratory Medicine
Verified
Journal Article
Open access
PDF file
EGEthan James Gantana
Ethan James Gantana
EMErnest Musekwa
Ernest Musekwa
ZCZivanai Cuthbert Chapanduka
Zivanai Cuthbert Chapanduka
The quantitation of plasma cells in bone marrow (BM) is crucial for diagnosing and classifying plasma cell neoplasms. Various methods, including Romanowsky-stained BM aspirates (BMA), immunohistochemistry, flow cytometry, and radiological imaging, have been explored. However, challenges such as patchy infiltration and sample haemodilution can impact the reliability of BM plasma cell percentage estimates. Bone marrow plasma cell percentage varies across methods, with immunohistochemically stained biopsies consistently yielding higher values than Romanowsky-stained BMA or flow cytometry alone. CD138 or MUM1 immunohistochemistry and artificial intelligence image analysis on whole-slide images are emerging as promising tools for accurate plasma cell identification and quantification. Radiological imaging, particularly with advanced technologies like dual-energy computed tomography and radiomics, shows potential for multiple myeloma diagnosis, although standardisation remains a challenge. Molecular techniques, such as allele-specific oligonucleotide quantitative polymerase chain reaction and next-generation sequencing, offer insights into clonality and measurable residual disease. While no consensus exists on a gold standard method for BM plasma cell quantitation, CD138-stained biopsies are favoured for accurate estimation and play a pivotal role in diagnosing and assessing multiple myeloma treatment responses. Combining multiple methods, such as BMA, BM biopsy, and flow cytometry, enhances accuracy of diagnosis and classification of plasma cell neoplasms. The quest for a gold standard requires ongoing research and collaboration to refine existing methods. Furthermore, the rise of digital pathology is anticipated to reshape laboratory medicine and the role of pathologists in the digital era. What this study adds: This article adds a comprehensive review and comparison of different methods for plasma cell estimation in the bone marrow, highlighting their strengths and limitations. The goal is to contribute valuable insights that can guide the selection of optimal techniques for accurate plasma cell estimation.

8 October 2021 in Journal of Clinical Pathology
Verified
Journal Article
Closed access
PDF file
EGEthan James Gantana
Ethan James Gantana
NMNomusa Mashigo
Nomusa Mashigo
IAIbtisam Abdullah
Ibtisam Abdullah
EMErnest Musekwa
Ernest Musekwa
RLRobert Lohlun
Robert Lohlun
ZCZivanai Cuthbert Chapanduka
Zivanai Cuthbert Chapanduka
Aim To compare the frequently used CD138 immunohistochemistry-based method of plasma cell quantitation, to a proposed new method, using interobserver and intraobserver concordance parameters. Methods Archival CD138 immunohistochemically stained slides made from paraffin-embedded bone marrow biopsies of 33 patients with a confirmed diagnosis of multiple myeloma were used. Light microscopic examination was performed using low magnification lenses (10×) for both the overview estimation method (method A) and the new method (method B), and high magnification lenses (50×), for method B only. For method B, reviewers selected three areas with low, intermediate and high plasma cell densities using 10× lenses. Using a well-defined technique, the 50× lens was then used to count plasma cells as a percentage of all nucleated cells. After blinded relabelling of all the slides, the nine reviewers repeated the plasma cell quantitation using both methods. The plasma cell counts were obtained, and the review times were recorded. Results Overall intraobserver concordance was comparable for method A (concordance correlation coefficient (CCC)=0.840) and method B (CCC=0.733). Interobserver concordance for method A (intraclass correlation coefficient (ICC)=0.793 and 0.713) and method B (ICC=0.657 and 0.658) indicated high similarity between reviewers. Method A showed poor interobserver concordance (ICC=0.105) at low plasma cell densities. Conclusions The new method is comparable to the frequently used overview estimation method in terms of intraobserver and interobserver concordance, and cost. The new method has superior interobserver concordance at low plasma cell densities. The new method appears more amenable to digital scanning and analysis.

23 December 2023 in Journal of the Colleges of Medicine of South Africa
Verified
Journal Article
Open access
PDF file
SCSumaiya Cassim
Sumaiya Cassim
ENErica-Mari Nell
Erica-Mari Nell
EGEthan James Gantana
Ethan James Gantana
EMErnest M. Musekwa
Ernest M. Musekwa
RLRobert K. Lohlun
Robert K. Lohlun
ZCZivanai Cuthbert Chapanduka
Zivanai Cuthbert Chapanduka
Background: The World Health Organization has updated its classification of haematolymphoid tumours to the new 5th edition. The International Consensus Classification is another group that has developed a separate classification system with similar but conflicting approaches. This led to a debate among haematologists about which classification system is more appropriate for clinical use. This article examines and compares these contrasting and concurring classifications, and provides insight into the utility of each system. Methods: Journal articles pertaining to WHO-HAEM4R, WHO-HAEM5 and ICC were searched for using the MEDLINE database, from November 2022 to November 2023. Original research articles and reviews were selected to compile this review. Results: The classification systems share many similarities with minor name changes and subgrouping. There are few instances where diagnostic grouping differs between the classifications, which could have clinical implications regarding treatment and enrolment in clinical trials. Conclusion: There is universal agreement about the need for objective criteria for the classification of haematolymphoid tumours. As a result, there have been considerable strides in the classification with regard to morphologic, immunophenotypic, molecular and cytogenetic characterisation. It is reassuring to have a stepwise approach to diagnosis, allowing developing countries to make appropriate diagnoses. Contribution: Harmonisation is needed for a universal diagnostic system for the benefit of the patient. Both classification systems have merit and either could be adopted by individual institutions at present. The authors appeal for interim advocacy measures to assure access to the specific diagnostic investigations in poorly resourced societies, pending more permanent and sustainable access.

3 August 2026 in Cytometry Part B: Clinical Cytometry
Verified
Journal Article
Open access
EGEthan James Gantana
Ethan James Gantana
EMErnest Musekwa
Ernest Musekwa
ENErica‐Mari Nell
Erica‐Mari Nell
ZCZivanai Cuthbert Chapanduka
Zivanai Cuthbert Chapanduka
Manual gating for plasma cell (PC) identification in multiparametric flow cytometry (MFC) is time‐consuming and operator‐dependent, especially when PCs are scarce. Artificial intelligence approaches such as unsupervised clustering (e.g., FlowSOM) map high‐dimensional data that still require expert interpretation. The primary aim of this work was to develop a lightweight, transparent, spreadsheet‐based algorithm for a classification model that integrates with automated clustering outputs for standardized B‐cell and PC identification in research flow cytometry datasets. Bone marrow aspirates were stained with a standard BD OneFlow™ PC screening tube (CD38, CD56, β2‐microglobulin, CD19, cyIgκ, cyIgλ, CD45, CD138) and acquired on a BD FACSLyric™ flow cytometer. FCS files were exported to CellEngine cytometry software and singlet nucleated events underwent FlowSOM clustering (8 clusters/sample). Cluster‐level median fluorescence intensities (MFIs) were exported to an Excel “PC Trainer Classifier” that (i) normalizes markers to an in‐sample B‐cell anchor, (ii) computes a PC score with CD138 as a hard gate and CD38 as a soft gate, plus secondary features (CD19↓, CD45↓, CD56↑), (iii) applies a forced core fallback (highest CD38/CD138 core score) when strict criteria yield no PCs, and (iv) derives a NEO score (CD56↑, CD19↓, CD45↓) for neoplastic phenotype. The rule‐based classifier was trained on expert assigned PC and B‐cell clusters from 40 samples (30 clonal and 10 polyclonal). Validation was done on a new set of 52 samples, independent of the model. Elements of the Excel formula design and error‐proofing were co‐developed with ChatGPT (OpenAI); all outputs were verified by the authors. Across 52 validation cases (8 clusters/case; 416 clusters total), B‐cell detection achieved: Sensitivity 0.902 (0.79–0.96), Specificity 0.984 (0.96–0.99), Precision 0.885 (0.77–0.94), Accuracy 0.973 (0.95–0.99) and F1 0.893. PC identification achieved: Sensitivity 0.651 (0.54–0.75), Specificity 0.828 (0.79–0.86), Precision 0.458 (0.37–0.55), Accuracy 0.796 (0.76–0.83) and F1 0.537. A transparent Excel‐based classifier integrated with FlowSOM clustering enables highly reproducible B‐cell identification and provides a structured approach to PC classification in research flow cytometry datasets. While the B‐cell classifier demonstrated excellent discriminatory performance, PC identification yielded moderate sensitivity and precision, likely reflecting underlying biological and phenotypic heterogeneity. Consequently, the PC classification component is best interpreted as a triage or augmented‐intelligence tool intended to support, rather than replace, expert assessment. This approach provides a structured and auditable framework that reduces operator dependency and improves inter‐case harmonization. Its interpretability, low cost and portability make it particularly suited to research laboratories operating in resource‐variable settings. Further optimisation and prospective validation may refine PC classification performance.